New gene variants associated with venous thrombosis: A replication study in White and Black Americans

Journal of Thrombosis and Haemostasis

Volumn 9, Issue 3, 2011, Pages 489-495

  Austin, H ^a   De Staercke, C ^b   Lally, C ^a   Bezemer, I D ^c   Rosendaal, F R ^c   Hooper, W C ^b  

^a EMORY UNIVERSITY   (United States)

^b NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Blacks; Genetics; Pulmonary embolism; Thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 11; CYTOCHROME P450 4V2; CYTOCHROME P450 ISOENZYME; GLYCOPROTEIN VI; PLASMA KALLIKREIN; SERINE PROTEINASE INHIBITOR; SERINE PROTEINASE INHIBITOR C1; UNCLASSIFIED DRUG;

ADULT; AFRICAN AMERICAN; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; GENE LINKAGE DISEQUILIBRIUM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; VEIN THROMBOSIS;

ADULT; AFRICAN AMERICANS; ANTITHROMBIN III; CASE-CONTROL STUDIES; CYTOCHROME P-450 ENZYME SYSTEM; EUROPEAN CONTINENTAL ANCESTRY GROUP; FACTOR XI; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUCOSE-6-PHOSPHATASE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; PLASMA KALLIKREIN; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY EMBOLISM; RISK FACTORS; VENOUS THROMBOSIS;

EID: 79952044991     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2011.04185.x     Document Type: Article

References (12)

1. Bezemer ID, Bare LA, Doggen CJ, Arellano AR, Tong C, Rowland CM, Catanese J, Young BA, Reitsma PH, Devlin JJ, Rosendaal FR. Gene variants associated with deep vein thrombosis. JAMA 2008; 299: 1306-14.
2. Austin H, Key NS, Benson JM, Lally C, Dowling NF, Whitsett C, Hooper WC. Sickle cell trait and the risk of venous thromboembolism among blacks. Blood 2007; 110: 908-12.
3. Meijers JC, Tekelenburg WL, Bouma BN, Bertina RM, Rosendaal FR. High levels of coagulation factor XI as a risk factor for venous thrombosis. N Engl J Med 2000; 342: 696-701.
4. Sham P. Statistics in Human Genetics. New York, NY: Oxford University Press Inc., 1998.
5. Devlin B, Risch N. A comparison of linkage disequilibrium measures of fine-scale mapping. Genomics 1995; 29: 311-22.
6. Hosmer DW, Lemeshow S. Applied Logistic Regression, 2nd edn. New York, NY: Wiley and Sons Inc., 2000.
7. Benjamini Y, Yekutieli D. The control of the false discovery rate in multiple testing under dependency. Ann Stat 2001; 29: 1165-88.
8. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci 2003; 100: 9440-5.
9. StataCorp. Stata Statistical Software: Release 10 College Station. TX: Stata Corporation LP, 2007.
10. Tregouet DA, Heath S, Saut N, Biron-Andreani C, Schved JF, Pernod G, Galan P, Drouet L, Zelenika D, Juhan-Vague I, Alessi MC, Tiret L, Lathrop M, Emmerich J, Morange PE. Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach. Blood 2009; 113: 5298-303.
11. Anton AI, Teruel R, Corral J, Minano A, Martinez-Martinez I, Ordonez A, Vicente V, Sanchez-Vega B. Functional consequences of the prothrombotic SERPINC1 rs2227589 polymorphism on antithrombin levels. Haematologica 2009; 94: 589-92.
12. Li Y, Bezemer ID, Rowland CM, Tong CH, Arellano AR, Catanese JJ, Devlin JJ, Reitsma PH, Bare LA, Rosendaal FR. Genetic variants associated with deep vein thrombosis: the F11 locus. J Thromb Haemost 2009; 7: 1802-8.